Endocrinol Metab.  2020 Mar;35(1):55-63. 10.3803/EnM.2020.35.1.55.

Potential Biomarkers to Improve the Prediction of Osteoporotic Fractures

Affiliations
  • 1Division of Endocrinology and Metabolism, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. umkbj0825@amc.seoul.kr

Abstract

Osteoporotic fracture (OF) is associated with high disability and morbidity rates. The burden of OF may be reduced by early identification of subjects who are vulnerable to fracture. Although the current fracture risk assessment model includes clinical risk factors (CRFs) and bone mineral density (BMD), its overall ability to identify individuals at high risk for fracture remains suboptimal. Efforts have therefore been made to identify potential biomarkers that can predict the risk of OF, independent of or combined with CRFs and BMD. This review highlights the emerging biomarkers of bone metabolism, including sphongosine-1-phosphate, leucine-rich repeat-containing 17, macrophage migration inhibitory factor, sclerostin, receptor activator of nuclear factor-κB ligand, and periostin, and the importance of biomarker risk score, generated by combining these markers, in enhancing the accuracy of fracture prediction.

Keyword

Fracture; Biomarkers; Bone density; Risk factors

MeSH Terms

Biomarkers*
Bone Density
Macrophages
Metabolism
Osteoporotic Fractures*
Overall
Risk Assessment
Risk Factors
Biomarkers
Full Text Links
  • ENM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error